Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$15.17 USD
-0.09 (-0.59%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $15.09 -0.08 (-0.53%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Mesoblast Limited has a market cap of $1.95B, which represents its share price of $15.26 multiplied by its outstanding shares number of 128.00M. As a small-cap company, MESO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MESO 15.17 -0.09(-0.59%)
Will MESO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MESO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MESO
Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
Mesoblast Limited (MESO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MESO: What are Zacks experts saying now?
Zacks Private Portfolio Services
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
What Awaits These 4 Biotech Stocks That More Than Doubled in 2024
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
Other News for MESO
12 Health Care Stocks Moving In Friday's Intraday Session
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
Mesoblast (MESO) Downgraded by Jefferies to Hold | MESO Stock News
12 Health Care Stocks Moving In Friday's Pre-Market Session
This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday